Performance Benchmark: Optimizing Staff Levels to Drive Growth in Medical Devices

Research Info
Download FREE Excerpt
ID: PSM-244
Price: $2700
Pages: 34
Questions? Call

919-403-0251

Features:
 6 Info Graphics
 18 Data Graphics
 100+ Metrics
Delivery Format:
 Shipped
Buy this research as part of a !
In a dynamic business environment where an organization’s growth goals shift rapidly, companies review and modify their marketing strategy, tactics, time and activities on a timely basis to match the product and business requirements. Data gathered through this study will aid organizations to benchmark strategic and tactical marketing activities with top companies in the medical device-healthcare sector, to support their product portfolio in driving corporate growth and profitability.

Sales and Marketing > Marketing Management


Download Free Excerpt

View TOC and List of Exhibits

Study Snapshot

Key Findings
d Industries Profiled:
Pharmaceutical; Medical Device; Health Care; Manufacturing; Biotech

Companies Profiled:
Abbott Laboratories; Becton Dickinson; Hospira; LifeScan; Medtronic; Respironics; BARD; Medrad; Cardinal Health; Response; Stryker

Study Snapshot

This research study aims to identify Staffing and Performance levels for the marketing activities against growth and margin rates, across the Medical Device sector. For improved understanding of optimal performance ranges, the importance of more than 15 critical performance factors was comprehensively analyzed.


Research partners participated in a benchmark field study that identified performance levels across a broad range of key business performance factors that include:

  • What staffing and productivity Levels exist across Medical Device companies?
  • What growth and profit margin levels characterize high performance?
  • What strategic marketing activities are most important and consume the greatest resources?

The report comprises valuable statistics and information relating to sales growth rates, profit margins, marketing staff FTEs, and product coverage benchmarks. In addition, a section on Marketing Excellence Benchmarks provides maximum, minimum, 75th percentile, 25th percentile, mean and median responses for sales growth, profit margins, marketing staff FTEs and product coverage benchmarks.

Back to Top

Key Findings

Successful branded Rx products have the potential to grow rapidly, thereby winning marketing resources to create demand. Growth rates for other categories tend to run 25-30 percent less.

  • Generic product tactical marketers carry twelve times more products than branded Rx product marketers and typically more products than medical device tactical marketers. Both generic and device tactical marketers tend to be charged with taxing product portfolios.

Back to Top

Related Research:

New Product Launch Spend: What It Takes To Win In The U.S. Market 
In today’s pharmaceutical industry–where the recent product launch landscape is marked by as many failures as successes—it is critical for launch teams to understand the right level of resources required to give each new product its best chance for gaining a market foothold... (ID PSM-262)
Companies Profiled: Abbott, ProStrakan, Sanofi-aventis, Regeneron, more ...
Price: $8000.00   Free Excerpt Available


Building and Sustaining Winning Competitive Intelligence Organizations 
In today’s fast changing business environment, the competitive intelligence organization can play a vital role in corporate success by helping companies anticipate and deploy strategic responses to external threats and opportunities... (ID SM-175)
Companies Profiled: Amgen, Sanofi-aventis, Boehringer-Ingelheim, Boeing, more ...
Price: $7995.00   Free Excerpt Available


Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters 
The findings in this Best Practices Benchmarking® Report will enable pharmaceutical executives to understand the winning strategies, practices, team structures and investment patterns that distinguish successful new product development and marketing planning... (ID SM-124)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Bristol-Myers Squibb, Amgen, more ...
Price: $7962.00   Free Excerpt Available


Developing the High-Performance Market Research Function 
Market research departments increasingly face this challenge to their primary roles: evolving from providers of support-level data to highly-valued business advisors for strategic decision-making... (ID SM-169)
Companies Profiled: AstraZeneca, Sanofi-aventis, Zurich North American, Towers Perrin, more ...
Price: $7949.00   Free Excerpt Available


Pharmaceutical New Product Commercialization: Preparing for Market Success 
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID SM-176)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $7795.00   Free Excerpt Available


Managing the Competition: Turning Competitive Intelligence into Strategy 
Learn how top corporate competitive intelligence organizations use competitor data to drive strategy and market success... (ID SM-157)
Companies Profiled: 3M Pharmaceuticals, Abbott Laboratories, Amgen, AstraZeneca, more ...
Price: $7502.00   Free Excerpt Available


Best Practices in Working with Patient Advocacy Groups: Building Effective Relationships 
Patient and professional advocacy groups play a crucial role in educating the marketplace on new medicines and treatments... (ID SM-185)
Companies Profiled: Abaxis, Abbott Laboratories, Allos Therapeutics, Amgen, more ...
Price: $7500.00   Free Excerpt Available


Raising Disease State Awareness: Best Practices in Internal Brand Messaging for New Products 
Educating the marketplace about disease state is crucial to the success of a new pharmaceutical product— especially if the product treats a medical condition that is previously unknown, socially sensitive or stigmatized or if the product is first in its class... (ID OP-106)
Companies Profiled: Abbott, Novartis, Actelion, Novo Nordisk, more ...
Price: $7200.00   Free Excerpt Available


Educating the Market: Creating Value Through Support of Continuing Medical Education 
As new therapies emerge, physicians and consumers alike face not only expanded treatment options but also the attendant challenge of choosing the most appropriate drug... (ID SM-180)
Companies Profiled: Alcon, Sanofi-Aventis, Amylin, AstraZeneca, more ...
Price: $6995.00   Free Excerpt Available


Medical Science Liaison Services Excellence: Generating Value for Diverse Customer Groups 
Biopharmaceutical and medical device companies find it increasingly challenging to deliver exceptional services to a diverse set of customers that may include regional Thought Leaders, important Clinical Investigators, local Opinion Leaders, Payer and Government Thought Leaders, and various internal stakeholders... (ID PSM-279)
Companies Profiled: Advanced Biohealing, Allergan, Amylin, AstraZeneca, more ...
Price: $6800.00   Free Excerpt Available


Collaborating with Patient Advocacy Groups to Educate the Marketplace 
Strong relationships with advocacy groups are fundamental for educating the public on most recent medical happenings, especially on socially-sensitive conditions and treatment options... (ID PSM-242)
Companies Profiled: Abbott Laboratories, Baxter Healthcare, Solvay Pharmaceuticals, Vital Therapies, more ...
Price: $6500.00   Free Excerpt Available


Clinical Trial Excellence: The Science & Art of Winning Investigators in a Competitive Marketplace 
In facing the dual challenge of recruiting investigators who will deliver patients and add credibility to their trials, clinical operations executives within pharmaceutical companies and CROs have had to develop sophisticated techniques to find, screen and win the support of investigators... (ID OP-94)
Companies Profiled: Amersham, Sanofi-aventis, ALTANA Pharmaceuticals, Amgen, more ...
Price: $6500.00   Free Excerpt Available


Oncology Global Strategic Marketing: Benchmarking Budget Levels & Service Scope 
Global Strategic Marketing (GSM) organizations in oncology often face crowded markets that require high performance and proficiency to be successful... (ID PSM-271)
Companies Profiled: Abbott, Selvita S.A., Astellas, AstraZeneca, more ...
Price: $6200.00   Free Excerpt Available


Educating The Market: Creating Value Through Support of Continuing Medical Education 
STUDY OVERVIEW With limited information on actual return on investment for expenditures toward support of Continuing Medical Education activities, Pharmaceutical and Biotechnology companies are anxious to understand the value of CME support and strategies for ensuring investments provide appropriate impact on healthcare practitioner behaviors and patient outcomes... (ID PSM-223)
Companies Profiled: Alcon Laboratories, Sanofi-aventis, Wyeth Pharmaceuticals, TAP, more ...
Price: $5995.00   Free Excerpt Available


Marketing Services Excellence: Driving Costs Down & Effectiveness Up 
Marketing organizations today are under increasing pressure to deliver quality services to their internal clients while holding down costs... (ID PSM-289)
Companies Profiled: Agility, Alargan, Astellas, BASF, more ...
Price: $5750.00


Government Affairs & Public Policy Excellence: Optimizing Group Structure & Operations 
Businesses today face tougher regulations and scrutiny, which necessitates strong Government Affairs and Public Policy groups that can direct and oversee complex matters in regards to public policy and legislation... (ID PSM-252)
Companies Profiled: Abbott, DRI, Novo Nordisk, Biomarin, more ...
Price: $5600.00   Free Excerpt Available


Lifecycle Management Excellence: High-Performing Strategies Used to Maximize Potential Of Mature Brands 
With fewer products in the pipeline and more at the edge of the patent cliff, strategies to extend the commercial life of mature brands are critical to the bio-pharmaceutical industry today... (ID PSM-283)
Companies Profiled: Novartis, Novo Nordisk, GlaxoSmithKline, Merck, more ...
Price: $5500.00   Free Excerpt Available


From Breakthrough to Blockbuster: Best Practices in Communicating Clinical Trial Results 
Pharmaceutical companies spend considerable resources conducting large clinical studies to support the launch of new products or expand indications for currently marketed products... (ID SM-166)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, AstraZeneca, Bristol-Myers Squibb, more ...
Price: $5362.00   Free Excerpt Available


Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone 
In today’s fast-changing, high-pressure marketplace, the Competitive Intelligence (CI) function helps companies anticipate external threats and opportunities in a timely manner so companies can respond strategically... (ID SM-179)
Companies Profiled: Alcon Labs, Sanofi-aventis, Biogen Idec, Centocor, more ...
Price: $5352.00   Free Excerpt Available


Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management 
Study Overview The advocacy of Key Opinion Leaders (KOLs) has proven to be among of the most effective and critical means of building product awareness in the medical and scientific communities... (ID PSM-235)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, URL Pharma, Transoma Medical, more ...
Price: $5200.00   Free Excerpt Available




All contents copyright 1998-2012 Best Practices, LLC (919) 403-0251
Site Map | Read our Privacy Policy and Copyright Information